OBIO — Orchestra Biomed Holdings Share News
0.000.00%
Last trade - 00:00- $366.04m
- $290.92m
- $33.48m
Brief: Orchestra Biomed Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Orchestra Biomed Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
Orchestra BioMed Q2 revenue drops, net loss widens
Brief: Orchestra BioMed Q2 EPS USD -0.38
Orchestra Biomed Holdings Inc expected to post a loss of 39 cents a share - Earnings Preview
Orchestra BioMed Q1 revenue falls and misses estimates
Brief: Orchestra BioMed Q1 EPS USD -0.33
Brief: Orchestra Biomed Announces Presentations Highlighting Avim Therapy Potential Impact On Hypertensive Heart Disease And Heart Failure At Tht And Crt
Brief: Orchestra Biomed To Receive Up To $21 Million In Proceeds From Acquisition Of Vivasure By Haemonetics
Brief: Orchestra BioMed Announces AVIM Therapy And Virtue SAB Program Presentations At ICI Meeting
Brief: Orchestra Biomed Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Orchestra BioMed Q3 revenue beats expectations
Brief: Orchestra BioMed Q3 EPS USD -0.4
Brief: Orchestra BioMed and Terumo Enter into New $30 Million Virtue SAB Strategic Agreements
Brief: Orchestra BioMed Announces First Patients Enrolled in Virtue® SAB US Pivotal IDE Coronary Trial
Brief: Orchestra Biomed Announces Rollout Of FDA-Approved Backbeat Global Pivotal Study Protocol Update Significantly Expanding Patient Eligibility
Brief: Orchestra Biomed Secures Over $111 Million In Proceeds And Committed Capital Following Completion Of Strategic Transactions And Concurrent Public And Private Equity Offerings
U.S. STOCKS ON THE MOVE-Imperial Oil, JPMorgan Chase, Pultegroup
U.S. STOCKS ON THE MOVE-CNH Industrial, Newmont, Dominion Energy